This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Axolabs Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
0
Company Filing History:
Years Active: 2026
Title: Kathrin Hultsch: Innovator in Muscular Dystrophy Treatment
Introduction
Kathrin Hultsch is a prominent inventor known for her contributions to the field of medical science, particularly in the treatment of facioscapulohumeral muscular dystrophy. Her innovative approach has led to significant advancements in therapeutic formulations.
Latest Patents
Hultsch holds a patent for "Muscle Targeting Complexes and Formulations for Treating Facioscapulohumeral Muscular Dystrophy." This patent represents her commitment to developing effective treatments for this challenging condition. She has 1 patent to her name.
Career Highlights
Kathrin Hultsch is associated with Axolabs GmbH, where she has been instrumental in research and development efforts. Her work focuses on creating targeted therapies that can improve the quality of life for patients suffering from muscular dystrophy.
Collaborations
Hultsch collaborates with notable colleagues, including Timothy Weeden and Nelson Hsia, to further her research and enhance the impact of her innovations.
Conclusion
Kathrin Hultsch's dedication to advancing medical treatments through her innovative patents highlights her significant role in the field of muscular dystrophy research. Her work continues to inspire and pave the way for future advancements in this area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile